Founded
Address
Lilly Ventures
115 W. Washington Street
South Tower 1680
Indianapolis, IN 46204
United States
Phone
Website
Recent investment activity
Tags
KANDO id: 30096
Corporate information
Registration country
Funding rounds
Top investment portfolio themes
micro-VC (1)
Actual initial investment stage
N/A (1)
Investment activity status
Active investor
Selected investments
Displaying 26 - 36 of 36Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Cylene Pharmaceuticals Inc | Clinical stage private company developing small molecule drugs against newly validated cancer targets. | Series D | ||||
Cylene Pharmaceuticals Inc | Clinical stage private company developing small molecule drugs against newly validated cancer targets. | Series C | ||||
Fluidigm Corp | Developer and manufacturer of microfluidic systems for markets in the life science and agricultural biotechnology industries. | Series E | ||||
Hemaquest Pharmaceuticals Inc | Series B | |||||
Hemaquest Pharmaceuticals Inc | Series B | |||||
Hemaquest Pharmaceuticals Inc | Series A | |||||
InnoCentive Inc | Series A | |||||
MedManage Systems Inc | Online drug sampling provider | N/A | ||||
Protagonist Therapeutics Inc | Biotechnology company dedicated to the discovery of novel peptide and small molecule compounds. | Series A | ||||
Trinity Biosystems Inc | Developer of a platform for the delivery of peptides across intact mucosal surfaces. | N/A | ||||
XenoPort Inc | N/A Initial investment |